¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"internal ribosomal entry site"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • internal inguinal ring
    ¾ÈÂÊ»ô±¼±¸¸Û, ³»¼­Çý·û
  • internal injury
    ³»ºÎ¼Õ»ó
  • internal irradiation
    ¸ö¼ÓÁ¶»ç, ³»ºÎÁ¶»ç
  • internal irradiation hazard
    ü³»ÇÇÆøÀ§Çè
  • internal jugular vein
    ¼Ó¸ñÁ¤¸Æ, ³»°æÁ¤¸Æ
  • internal mammary artery
    ¼Ó°¡½¿µ¿¸Æ, ³»È䵿¸Æ
  • internal medicine
    1. ³»°ú 2. ³»°úÇÐ
  • internal medullary lamina
    ¼Ó¼¶À¯ÆÇ, ³»¼öÁúÆÇ
  • internal oblique abdominal muscle
    ¹è¼Óºø±Ù, ³»º¹»ç±Ù
  • internal ophthalmoplegia
    ¼Ó´«±ÙÀ°¸¶ºñ, ³»¾È±Ù¸¶ºñ
  • internal os
    ¼Ó±¸¸Û, ³»°ø
  • internal pacemaker
    ü³»¹Úµ¿Á¶À²±â
  • internal pelvimetry
    ¼Ó°ñ¹ÝÃøÁ¤¹ý
  • internal phase
    ºÐ»ê±â
  • internal pile
    ¼ÓÄ¡ÇÙ, ³»Ä¡ÇÙ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • internal hemorrhoid
    ¼ÓÄ¡Áú
  • internal hordeolum
    ¼Ó´Ù·¡³¢, ³»¸Æ¸³Á¾
  • internal irradiation hazard
    ü³»ÇÇÆøÀ§Çè
  • internal
    ¼Ó-, ³»-
  • internal injury
    ³»ºÎ¼Õ»ó
  • internal irradiation
    ü³»Á¶»ç
  • internal medicine
    ³»°úÇÐ
  • internal ophthalmoplegia
    ¼Ó´«±ÙÀ°¸¶ºñ
  • internal pacemaker
    ü³»¹Úµ¿Á¶À²±â
  • internal parasitism
    ³»ºÎ±â»ý»ýȰ
  • internal pelvimetry
    ¼Ó°ñ¹ÝÃøÁ¤¹ý
  • internal phase
    ³»»ó
  • internal pile
    ³»Ä¡ÇÙ
  • internal resistance
    ³»ºÎÀúÇ×
  • internal resorption
    ü³»Èí¼ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • canal, internal acoustic
    ³»À̵µ
  • canal, internal auditory
    ³»À̵µ
  • ear, inner =internal e.
    ³»ÀÌ
  • ear, internal
    ³»ÀÌ
  • fundus of internal acoustic meatus
    ¼Ó±Í±æ¹Ù´Ú
  • genu of internal capsule
    ¼Ó¼¶À¯¸·¹«¸­
  • inner ear =internal e.
    ³»ÀÌ
  • inner ear =internal e.
    ³»ÀÌ(Ò®ì¼).
  • inner language =internal speech
    ³»¾ð¾î
  • internal
    ¼Ó ³»
  • internal QC
    ³»ºÎ QC
  • internal absorption
    ³»ºÎÈí¼ö(¡­ýåâ¥).
  • internal acoustic canal
    ³»À̵µ
  • internal acoustic meatus
    ³»À̵µ(Ò®ì¼Ô³).
  • internal acoustic meatus
    ¼Ó±Í±æ ³»À̵µ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Internal longitudinal layer
    ¼Ó¼¼·ÎÃþ
    [¿¾ ¿ë¾î] ³»Á¾ÁÖÃþ
  • Internal glial limiting membrane
    ¼Ó¾Æ±³¼¼Æ÷°æ°è¸·
    [¿¾ ¿ë¾î] ³»±³°æ°è¸·
  • Internal axis of bulb
    ¼Ó¾È±¸Ãà
    [¿¾ ¿ë¾î] ³»¾È±¸Ãà
  • Internal iliac artery
    ¼Ó¾ûµ¢µ¿¸Æ
    [¿¾ ¿ë¾î] ³»Àå°ñµ¿¸Æ
  • Internal iliac artery (partial)
    ¼Ó¾ûµ¢µ¿¸Æ(ºÎºÐ)
    [¿¾ ¿ë¾î] ³»Àå°ñµ¿¸Æ
  • Internal iliac lymph nodes
    ¼Ó¾ûµ¢¸²ÇÁÀý
    [¿¾ ¿ë¾î] ³»Àå°ñÀÓÆÄÀý
  • Internal iliac vein
    ¼Ó¾ûµ¢Á¤¸Æ
    [¿¾ ¿ë¾î] ³»Àå°ñÁ¤¸Æ
  • Internal urethral opening
    ¼Ó¿äµµ±¸¸Û
    [¿¾ ¿ë¾î] ³»¿äµµ±¸
  • Internal pudendal artery
    ¼ÓÀ½ºÎµ¿¸Æ
    [¿¾ ¿ë¾î] ³»À½ºÎµ¿¸Æ
  • Internal pudendal vein
    ¼ÓÀ½ºÎÁ¤¸Æ
    [¿¾ ¿ë¾î] ³»À½ºÎÁ¤¸Æ
  • Internal seprmatic fascia
    ¼ÓÁ¤»è±Ù¸·
    [¿¾ ¿ë¾î] ³»Á¤»è±Ù¸·
  • Internal filum terminale [Pial filum terminale]
    ¼ÓÁ¾¸»²ö [¿¬Áú¸·Á¾¸»²ö]
    [¿¾ ¿ë¾î] ³»Á¾»ç
  • Internal sheath
    ¼ÓÁý
    [¿¾ ¿ë¾î] ³»ÃÊ
  • Internal acrosomal membrane
    ¼Ó÷´Üü¸·
    [¿¾ ¿ë¾î] ÷´Üü³»¸·
  • Internal layer
    ¼ÓÃþ
    [¿¾ ¿ë¾î] ³»Ãþ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cos site
    cos ÀÚ¸®
  • donor site
    °ø¿©ÀÚ(Íêæ¨í­) ÀÚ¸® = peptidyl site
  • donor splicing site
    "°ø¿©ÀÚ ½ºÇöóÀÌ½Ì ÀÚ¸®, °ø¿©ÀÚ Àß¶óÀÕ±â ÀÚ¸®, (ÔÒ) splicing junctions"
  • D-site
    D-ÀÚ¸® (ÔÒ) donor site
  • E site
    E ÀÚ¸®
  • excluded site binding
    ¹èÁ¦(ÛÉð¶)ÀÚ¸® °áÇÕ(Ì¿ùê)
  • flexible active site
    °¡º¯(ʦܨ) Ȱ¼º(üÀàõ)ÀÚ¸®
  • fragile site
    Ãë¾àºÎÀ§(öªå°Ý»êÈ)
  • half-site editing
    ¹Ý(Úâ)ÀÚ¸® ÆíÁý(øºòþ)
  • interacting site
    »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ) ÀÚ¸®
  • mutable site
    °¡º¯ÀÌ(ʦܨì¶)ÀÚ¸®
  • Ori site
    Ori ÀÚ¸®
  • peptidyl site
    ÆéŸÀ̵å ÀÚ¸®
  • peptidyl-tRNA site
    ÆéŸÀ̵å-tRNA ÀÚ¸®
  • polycloning site
    ´Ù(Òý)Ŭ·Î´× ÀÚ¸®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
EOD entry on duty; every other day
OE on examination; order entry [system]; orofacial cleft; orthopedic examination; otitis externa; out-s...
PE Edinburgh Pharmacopoeia; pancreatic extract; paper electrophoresis; partial epilepsy; pelvic examina...
PofE portal of entry
RDES remote data entry system
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
RSK ribosomal S kinase
r-protein Ribosomal protein
rp Ribosomal protein
SSU rRNA Small subunit ribosomal RNA
SSU rDNA Small-subunit ribosomal DNA
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • internal pudendal artery
    ³»À½ºÎ µ¿¸Æ
  • internal respiration
    ³»È£Èí
    Á¶Á÷ ¼¼Æ÷¿¡¼­ÀÇ °¡½º ±³È¯.
  • internal root sheath
    ³»±ÙÃÊ
  • internal stress
    ³»ºÎ ÀÀ·Â
  • internal tunics of eyeball
    ¾È±¸ ¼ÓÃþ
  • internal wall
    ¼Óº®
  • lateral costal branch of internal thoracic artery
    ³»Èä°û µ¿¸ÆÀÇ ¿ÜÃø ´Á°ñÁö
  • orifice of internal acoustic meatus
    ³»À̵µ ±¸¸Û, ³»°ø±â
  • rigid internal fixation
    °ß°í³» °íÁ¤
  • serous internal pachymeningitis
    Àå¾×¼º ³»°æ °æ¼ö¸·¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
Con A binding site <biochemistry> A common misuse of the term receptor. Con A binds to the mannose residues of many different glycoproteins and glycolipids and the binding is therefore not to a specific site.
It could be argued that the receptor is the Con A and cells have Con A ligands on their surfaces: certainly this would be less confusing.
(05 Jan 1998)
multiple cloning site Region of a phage or plasmid vector that has been engineered to contain a series of restriction sites that are usually unique within the entire vector. This makes it particularly easy to insert or excise (subclone) DNA fragments.
(18 Nov 1997)
mutagenesis, site-directed Mutagenesis where the mutation is caused by in vitro induction directed at a specific site in a DNA molecule. The most common method involves use of a chemically synthesised oligonucleotide mutant which can hybridise with the DNA target molecule. The resulting mismatch-carrying DNA duplex may then be transfected into a bacterial cell line and the mutant strands recovered.
(12 Dec 1998)
polycloning site Region of a phage or plasmid vector that has been engineered to contain a series of restriction sites that are usually unique within the entire vector. This makes it particularly easy to insert or excise (subclone) DNA fragments.
(18 Nov 1997)
cos site <molecular biology> A 12-nucleotide bases-long segment of single stranded DNA that exists at both ends of the bacteriophage lambda's double-stranded genome.
The two cos sites at the ends of the genome are complementary to one another so that the genome can become circular once the virus has infected a host bacterium. The circular genome can then be duplicated continuously until there are many repeats of it strung together, the cos sites show the virus where to cut them apart right before they are packaged into individual capsids as new progeny viruses ready to infect more host cells.
(10 Nov 1998)
privileged site An anatomic area lacking lymphatic drainage, such as the brain, cornea, and hamster cheek pouch, in which heterologous tumours may grow because the host does not become sensitised.
(05 Mar 2000)
P site <molecular biology> The peptidyl tRNA binding site on the ribosome, the one to which the growing chain is attached, the incoming aminoacyl tRNA attaches to the A site.
(18 Nov 1997)
secondary site A second site in which cancer is found. Example: cancer in the lymph nodes near the breast is a secondary site.
(09 Oct 1997)
sequence tagged site <molecular biology> Short (200 to 500 base pairs) DNA sequence that has a single occurrence in the human genome and whose location and base sequence are known.
Detectable by PCR, sequence tagged sites are useful for localising and orienting the mapping and sequence data reported from many different laboratories and serve as landmarks on the developing physical map of the human genome.
Expressed sequence tags are sequence tagged sites derived from cDNAs.
(11 Jun 1998)
sequence-tagged site map A map representing the order and spacing of sequence-tagged sites within a stretch of DNA.
(05 Mar 2000)
hypersensitive site <molecular biology> A short segment of DNA which is especially prone to being cleaved by endonuclease enzymes like DNase.
These sites tend to be within gene promoter regions.
(11 Jan 1998)
site The spatial confines of a particular project.
(09 Oct 1997)
site-directed mutagenesis <molecular biology> Any of several methods used to create specific alterations in a gene.
(09 Oct 1997)
site potential tree A tree that has attained the average maximum height possible given site conditions where it occurs.
(05 Dec 1998)
site preparation Various treatments applied to a harvested area to promote regeneration of the site.
(05 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á